
The Symplicity Spyral Renal Denervation System's efficacy is debated by the FDA panel, with concerns about its effectiveness outweighing its benefits.


coremsg

The FDA's Circulatory System Devices Panel unanimously agreed that Medtronic's Spyral Renal Denervation device was safe, but the panel was split on its efficacy and whether its benefits outweigh the risks.

FDA Panel Split on Efficacy of Spyral Renal Denervation

fda-panel-split-on-efficacy-of-spyral-renal-denervation


FDA Panel Split on Efficacy of Spyral Renal Denervation
